Page last updated: 2024-11-04

gatifloxacin and Diarrhea

gatifloxacin has been researched along with Diarrhea in 4 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.

Research Excerpts

ExcerptRelevanceReference
"Shigella infections are a leading cause of diarrhoeal death among children in low-income and middle-income countries."2.55Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis. ( Atlas, HE; Brander, RL; Pavlinac, PB; Pernica, JM; Tickell, KD; Walson, JL, 2017)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tickell, KD1
Brander, RL1
Atlas, HE1
Pernica, JM1
Walson, JL1
Pavlinac, PB1
Gaynes, R1
Rimland, D1
Killum, E1
Lowery, HK1
Johnson, TM1
Killgore, G1
Tenover, FC1
Khurana, A1
Vinayek, N1
Recco, RA1
Go, ES1
Zaman, MM1
Leroi, MJ1
Siarakas, S1
Gottlieb, T1

Reviews

1 review available for gatifloxacin and Diarrhea

ArticleYear
Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis.
    The Lancet. Global health, 2017, Volume: 5, Issue:12

    Topics: Anti-Bacterial Agents; Child; Diarrhea; Dysentery, Bacillary; Fluoroquinolones; Gatifloxacin; Guidel

2017

Other Studies

3 other studies available for gatifloxacin and Diarrhea

ArticleYear
Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Mar-01, Volume: 38, Issue:5

    Topics: Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; D

2004
The incidence of Clostridium difficile-associated and non-C. difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute-care facility.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Aug-15, Volume: 39, Issue:4

    Topics: Clostridioides difficile; Clostridium Infections; Diarrhea; Emergency Medical Services; Fluoroquinol

2004
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:1

    Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections;

2002